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INTRODUCTION: 
Diclofenac sodium (DFS) is popular non- steroidal anti-
inflammatory drug. Upon oral admin istration it undergoes 
first pass metabolism and because of its short biological 
half- life, the drug has to be administered frequently. The 
physicochemical, pharmacokinetic and pharmacological 
properties of this drug make it well suited for transdermal 
drug development as the biological half life of the DFS is 
less than 4hrs (1.2to2hrs),molecular weight is less than 400 
Dalton (296 Dalton), dose of drug is less 20mg/day for 
transdermal administration. The DFS is neither highly 
lipophilic, nor highly hydrophilic and it is suitable for 
transdermal delivery but shows low permeability and 
hence not easily absorbed on transdermal applicat ion
1,2
. 
To overcome the less permeability of drugs through the 
skin, fewer strategies have been used. Most of them use 
penetration enhancer which is a popular technique. These 
agents partition into, and interact with, the stratum 
corneum constituents to induce a temporary, reversible 
increase in skin permeability. Usually, terpenes enhance 
drug permeat ion by any of the following three 
mechanis ms: disruption of the highly ordered lipid  
structure of stratum corneum; increased drug diffusivity in 
stratum corneum or increased drug partitioning into 
stratum corneum
3
. 
Therefore many compounds, such as  terpenes (geraniol 
and menthol), isopropyl myristate, nicotinic acid esters, 
hydrogenated soya phospholipid, ethanol, n-octanol and 
decanol and nonionic surfactants have been reported to 
enhance the permeation of DFS through the skin 
4-9
. Out of 
them terpenes are widely used as penetration enhancers
 10
. 
The calendula oil is a volatile oil d istilled from flowers of 
Calendula officinalis (Asteraceae). After systematic 
studies, the various constituents  of this oil found were α-
cadinene, α-cadinol, t-muurolo l, menthol, 1,8-cineol, 
terpene-4-ol,geraniol with p-cymene
11,12
. 
The enhancing effect of calendula oil on the in vitro 
percutaneous absorption of diclofenac sodium (DFS) from 
carbopol gels containing propylene glycol was investigated 
in artificial skin membrane considering the fact that the 
calendula oil a lso contains different terpenes  which have 
been identified by GC-MS analysis
12
. The permeat ion 
effect of calendula oil on DFS is compared with geraniol 
and menthol (mild accelerants). 
MATERIALS AND METHOD: 
Materials: 
Diclofenac sodium (a g ift sample o f Zim laboratory Pvt. 
Ltd. India), carbopol (Loba chemicals), propylene glycol 
and triethanolamine (Fine chemical), geraniol and menthol 
(BASF,Mumbai), calendula o il (ext racted from calendula 
flowers by using Clevenger apparatus) and artificial skin  
membrane (Dialysis membrane 70 Code-DM003: LA 393-
1MT HIMEDIA).  
Drug formulations: 
The gel were prepared by adding 1% drugs in the 
formulat ion shown in Table 1.  
Characterization of gel: 
pH:  
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The pH of various gel formulations was determined by 
using digital pH meter. One gram of gel was dissolved in 
100 ml distilled water and stored for 30 minutes. The 
measurement of pH of each formulation was done in 
triplicate and average values were calcu lated.  
Table 1: Different formulations of DFS gel  
INGREDIENTS  
(gm) 
F1  F2  F3  F4  
Diclofenac 
sodium 
1 1 1 1 
Carbopol  2 2 2 2 
Propylene glycol 15 15 15 15 
Geraniol -- 1 -- -- 
Menthol  -- -- 1 -- 
Calendula oil -- -- -- 1 
Triethanolamine  3.50 3.50 3.50 3.50 
Water  (ad 100 gm) 
 
Drug content:  
1 g of the prepared gel was mixed with 100ml phosphate 
buffer. A liquots of different concentration were prepared  
by suitable dilutions after filtering the stock solution and 
absorbance was recorded using UV spectrophotometer at 
276 nm. Drug content was calculated using the equation, 
which was obtained by linear regression analysis of 
calibrat ion curve.  
Viscosity:  
The measurement of viscosity of the prepared gel was 
done with a Brookfield Viscometer. The gels were rotated 
at 100 rotations per minute and the corresponding dial 
reading was noted. The viscosity of the gel was obtained 
by mult iplication of the dial reading with factor given in  
the Brookefield Viscometer catalogues.  
Spreadability:  
One of the criteria for a gel to meet the ideal quantities is 
that it should possess good spreadability. It is the term 
expressed to denote the extent of area to which gel readily  
spreads on application to skin or affected part. The 
therapeutic efficacy of a formulation also depends upon its 
spreading value.  
Spreadability (S) is expressed in terms of time in seconds 
taken by two slides to slip off from gel and placed in 
between the slides under the direction of certain load. 
Lesser the time taken for separation of two slides, better 
the spreadability. It is calcu lated by using the formula:  
S = M× L / T  
Where M = wt. tied to upper slide  
            L = length of glass slides  
            T = t ime taken to separate the slides  
Extrudability study: 
The formulat ions were filled into collapsible metal tubes 
after the gels were set in the container. The extrudability of 
formulat ion was determined.   It is a usual empirical test to 
measure the force required to extrude the material from 
tube. In the present study, the method adopted for 
evaluating gel formulation for ext rudability was based 
upon the quantity of gel and gel extruded from lacquered 
aluminum co llapsible tube on application of weight in  
grams required to extrude at least 0.5 cm ribbon of gel in 
10 seconds. More quantity extruded better was 
extrudability. The values of gel formulat ions obtained are 
shown in Table 2. 
Table 2: Characterization of gel formulations 
Test F1  F2  F3  F4  
pH 6.5±0.2 6.8±0.4 6.7±0.5 6.8±0.3 
Drug content (% ) 98.97±1.2 98.55±0.9 98.75±0.5 99.15±1.5 
Viscosity(cps) 6800±50 6800±70 6700±55 6600±65 
Spreadability(g.cm/sec) 6.85±0.15 6.45±0.10 7.05±0.35 7.10±0.3 
Extrudability Excellent Excellent Excellent Excellent 
Values are the mean ± S.E. of three determinations at 37°C (N=3).  
In- vitro permeation study:  
The artificial skin membrane  was equilibrated in isotonic 
phosphate buffer (pH 7.4) for 2 h before being mounted on 
a Franz-type diffusion cell with an available diffusion area 
of 1.76 cm
2
.The receptor phase consisted of a phosphate 
buffer solution (pH 7.4, 25 ml), stirred at 600 rpm with the 
help of magnetic bead and maintained at 37°C. The 
synthetic semi-permeable membrane was mounted 
between the donor and receptor compartments. The gel (1 
g) formulation was applied to the membrane. Samples 
were withdrawn through sample port of the Franz diffusion 
cell at predetermined time interval over 24 hours and 
analyzed by UV spectrophotometer at 276 nm. The 
receptor phase was immediately replenished with equal 
volume of phosphate buffer solution of pH 7.4. 
The permeat ion profiles of DFS through artificial skin  
membrane from plain carbopol gels (F1), containing 
calendula oil (F4) and different terpene (F2, F3) as 
penetration enhancers  are given in Fig. 1. The flux, J, was 
determined from the slopes at steady-state and the lag time 
from the x-intercept. The permeability coefficient, Kp, was 
estimated from the flux and the donor drug concentration. 
The effects of calendula oil and terpene enhancers on DFS 
permeat ion parameters are summarized in Table 3. 
Penetration-enhancing activities are expressed as 
enhancement ratios(ER) which is the ratio of the Kp value 
with enhancer to that obtained with plain carbopol gel. The 
flux values of different gel formulations are shown in 
Figure 2. 
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Figure 1: Permeation profile of diclofenac sodium 
through artificial  skin membrane from carbopol  gel 
containing calendula oil and terpenes as penetration 
enhancers. Each points represents the ± S.E. of two to 
three experiments.  
Enhancement ratio (ER) = Kp value of enhancer gel/ Kp  
value of plain gel 
Permeability coefficient (Kp) = flux value/donor drug 
concentration 
 
 
Figure 2: Flux values of di fferent gel formulations 
Table 3: Effects of calendula oil and terpenes enhancer on DFS permeation parameters 
a
 
Enhancer J(µg/cm
2
.h) Kp ×10
-3
(cm/hrs) Lag  time(h) ER  
Plain gel 10.61±0.5 1.061±0.006 0.34±0.2 31.20±1.7 
Geraniol 170.7±2.5 17.07±0.5 0.73±0.3 233.83±3.5 
Menthol  144.4±4.3 14.44±0.8 0.95±0.2 152±3.9 
Calendula oil 184.4±3.7 18.44±0.7 0.4±0.08 461±5.7 
a
 Values are the mean ± S.E. of  three determinations at 37°C (N=3). 
RES ULTS AND DISCUSS ION: 
These results demonstrate that the calendula oil is an effective accelerant for DFS drug as compared to geraniol and 
menthol. The most outstanding penetration enhancer was calendula oil, providing an almost 20-fo ld increase in DFS 
permeability coefficient, fo llowed by geraniol, and then menthol. Eventhough penetration enhancing effects of geraniol are 
closely related with calendula oil, the skin care properties of calendula oil may be an added advantage and it can be used in 
various transdermal commercial formulations as an effective penetration enhancer. 
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